TickerStat.comwe like data

NeuroSense Therapeutics Ltd. (NRSN)

Price$0.5108Cached quote
NRSNNasdaq
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2025202420232022202120202019
Revenue$0$0$0$0———
Research & development$6.2M$5.7M$7.3M$5.6M———
Operating expenses$11.1M$9.9M$12.0M$10.6M———
Operating income−$11.1M−$9.9M−$13.3M−$13.6M−$5.6M−$2.9M−$1.2M
EBITDA−$11.1M−$9.9M−$13.3M−$13.5M−$5.6M−$2.9M—
Net income−$11.1M−$10.2M−$11.3M−$12.3M−$4.0M−$2.8M−$1.2M
Basic EPSper basic share-$0.44-$0.54-$0.83-$1.07-$0.65-$0.51-$0.26
Diluted EPSper diluted share-$0.44-$0.54-$0.83-$1.07-$0.65-$0.51—
Review official source filings ↗

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 12 reported holders of NRSN
HolderShares held
UBS Group AG
108.64K
Independent Advisor Alliance
100K
Yorkville Advisors Global, LP
78K
COMMONWEALTH EQUITY SERVICES, LLC
22.78K
PNC Financial Services Group, Inc.
21.15K
Pathstone Holdings, LLC
16.53K
GEODE CAPITAL MANAGEMENT, LLC
15.87K
XTX Topco Ltd
11.47K
Creative Planning
11.41K
HRT FINANCIAL LP
10.52K
JONES FINANCIAL COMPANIES LLLP
1K
SBI Securities Co., Ltd.
255

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys2$400.0K disclosed value
Sells (SEC code S)0$0.00 disclosed value
2 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 16, 2026Form 4Ben-Noon AlonChief Executive OfficerBuyOrdinary Shares250.0K$0.80$200.0K4.53M
Jun 16, 2026Form 4Eisenberg OrChief Financial OfficerBuyOrdinary Shares250.0K$0.80$200.0K1.50M
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about NRSN yet. Start the conversation.

Write the first post